Open access
Sep 2026
Preclinical identification of an oxadiazole-pyrazole lead targeting prostate cancer through integrated mechanistic evaluation
Prostate cancer remains a major cause of cancer-related mortality among men, while resistance to androgen deprivation therapy emphasizes the need for new therapeutic strategies. Molecular hybridization of pharmacologically relevant heterocycles offers a rational approach for developing novel anticancer agents....
Vanktesh Kumar, Pankaj Wadhwa, Shubham Kumar
· Frontiers in Oncology · 0 citations